During the past decade, the 53 Member States of the WHO European Region, 31 of which are part of the European Union/European Economic Area, invested considerably in pandemic preparedness. This came in the wake of global threats posed by (re-)emerging diseases such as avian influenza A(H5N1) and...

During the past decade, the 53 Member States of the WHO European Region, 31 of which are part of the European Union/European Economic Area, invested considerably in pandemic preparedness. This came in the wake of global threats posed by (re-)emerging diseases such as avian influenza A(H5N1) and...

This focused after-action review (AAR), conducted by ECDC in collaboration with the Finnish Institute for Health and Welfare (THL), investigated the use of evidence in the Finnish advice-making process for school interventions from December 2021 to January 2022, when the SARS-CoV-2 Omicron...

This core protocol for ECDC studies of VE against hospitalisation with severe acute respiratory infection (SARI) laboratory-confirmed with SARS-CoV-2 or with influenza, version 4.0, represents an update to the main elements for a multi-country hospital-based study of COVID-19 vaccine...

The European Centre for Disease Prevention and Control (ECDC) has developed a monitoring system for hepatitis B and C to support countries in the European Union (EU) and European Economic Area (EEA) in monitoring responses to their epidemics of hepatitis B and C. The monitoring system is closely...

This document outlines key strategic and operational considerations to inform pandemic preparedness planning around the design and implementation of PHSMs in community settings in the European Union (EU) and European Economic Area (EEA).

At the request of the Slovenian National Institute of Public Health (NIJZ), ECDC designed and facilitated an After- Action review (AAR) for the NIJZ, focusing on the response to the COVID-19 pandemic between October 2020 to March 2021. ECDC managed the methodological approach and were the...

In 2021 and 2022, a survey was developed to assess the impact of COVID-19 on HIV service delivery and monitoring capacity in Europe and Central Asia. Countries were asked whether COVID-19 had an impact on several HIV-specific and non-HIV specific services compared to pre-COVID levels. Although...